REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$8.69
+0.81%
Mkt Cap $452.17M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $43.96M | $30.34M | -30.99% | -$1.01 | -$1.30 | -28.71% | — | — |
| Q4 2025 Nov 6, 2025 | $59.26M | $29.73M | -49.83% | -$1.38 | -$1.20 | +13.04% | — | — |
| Q3 2025 Aug 7, 2025 | $110.02M | $21.36M | -80.59% | -$1.13 | -$1.38 | -22.12% | — | — |
| Q2 2025 May 12, 2025 | $105.35M | $89.01M | -15.51% | $0.41 | $0.12 | -70.73% | — | — |
| Q1 2025 Mar 13, 2025 | $23.70M | $21.21M | -10.51% | -$1.27 | -$1.01 | +20.47% | — | — |
| Q4 2024 Nov 6, 2024 | $23.45M | $24.20M | +3.20% | -$1.16 | -$1.17 | -0.86% | — | — |
| Q3 2024 Aug 1, 2024 | $24.33M | $22.30M | -8.36% | -$1.29 | -$1.05 | +18.60% | — | — |
| Q2 2024 May 8, 2024 | $23.52M | $15.62M | -33.58% | -$1.28 | -$1.38 | -7.81% | — | — |
| Q1 2024 Feb 27, 2024 | $34.00M | $22.21M | -34.67% | -$1.27 | -$1.43 | -12.60% | — | — |
| Q4 2023 Nov 8, 2023 | $36.09M | $28.91M | -19.88% | -$1.44 | -$1.41 | +2.08% | — | — |
| Q3 2023 Aug 2, 2023 | $34.50M | $19.98M | -42.10% | -$1.26 | -$1.66 | -31.75% | — | — |
| Q2 2023 May 3, 2023 | $30.60M | $19.14M | -37.46% | -$1.52 | -$1.53 | -0.66% | — | — |
| Q1 2023 Feb 28, 2023 | $37.45M | $31.34M | -16.30% | -$1.48 | -$1.38 | +6.76% | — | — |
| Q4 2022 Nov 3, 2022 | $30.81M | $26.51M | -13.96% | -$1.55 | -$1.75 | -12.90% | — | — |
| Q3 2022 Aug 3, 2022 | $28.31M | $32.65M | +15.31% | -$1.44 | -$1.58 | -9.72% | — | — |
| Q2 2022 May 4, 2022 | $27.22M | $22.22M | -18.37% | -$1.29 | -$1.62 | -25.58% | — | — |
| Q1 2022 Mar 1, 2022 | $427.83M | $398.65M | -6.82% | $4.71 | $6.67 | +41.61% | — | — |
| Q4 2021 Nov 2, 2021 | $31.49M | $30.77M | -2.28% | -$0.87 | -$1.37 | -57.47% | — | — |
| Q3 2021 Aug 9, 2021 | $29.02M | $22.04M | -24.07% | -$1.08 | -$1.36 | -25.93% | — | — |
| Q2 2021 May 5, 2021 | $23.23M | $18.88M | -18.71% | -$1.13 | -$1.20 | -6.19% | — | — |